Fagan Associates’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-36,171
| Closed | -$2.7M | – | 127 |
|
|
2021
Q3 | $2.7M | Sell |
36,171
-17,873
| -33% | -$1.34M | 0.59% | 49 |
|
|
2021
Q2 | $5M | Buy |
54,044
+4,798
| +10% | +$444K | 1.07% | 28 |
|
|
2021
Q1 | $4.37M | Sell |
49,246
-229
| -0.5% | -$20.3K | 1.02% | 29 |
|
|
2020
Q4 | $4.61M | Buy |
49,475
+12,943
| +35% | +$1.21M | 1.16% | 26 |
|
|
2020
Q3 | $2.33M | Buy |
36,532
+24,792
| +211% | +$1.58M | 0.67% | 43 |
|
|
2020
Q2 | $612K | Buy |
+11,740
| New | +$612K | 0.2% | 72 |
|
|
2020
Q1 | – | Sell |
-6,766
| Closed | -$227K | – | 102 |
|
|
2019
Q4 | $227K | Buy |
+6,766
| New | +$227K | 0.07% | 113 |
|